We are live on ! Find out more
FONR

Fonar

Delisted

FONR was delisted on the 2nd of June, 2026.

43 hedge funds and large institutions have $41.6M invested in Fonar in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 10

1.02% less ownership

Funds ownership: 45.96%44.94% (-1%)

9% less funds holding

Funds holding: 4743 (-4)

9% less capital invested

Capital invested by funds: $45.7M → $41.6M (-$4.06M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
43
Holders Change
-4
Holders Change %
-8.51%
% of All Funds
0.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
11
Reduced
10
Closed
4
Calls
Puts
Net Calls
Net Calls Change

FONR Hedge Fund Activity: Q3 2022 in Review

43 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Fonar (FONR) for Q3 2022, worth a combined $41.6M — down 8.9% from $45.7M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of FONR and 0 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 11 added.

The largest buyer was Invenomic Capital Management, adding an estimated $1.01M. The largest seller was Kayne Anderson Rudnick Investment Management, cutting an estimated $704K.

  • 43 institutional investors held Fonar (FONR) as of Q3 2022, down from 47 in Q2 2022.
  • Funds reported $41.6M of Fonar stock for Q3 2022, down 8.9% quarter-over-quarter.
  • 0 funds opened new Fonar positions in Q3 2022 and 4 closed out, a net change of -4 holders.
  • The largest Fonar buyer in Q3 2022 was Invenomic Capital Management, an estimated $1.01M added.
  • The largest Fonar seller in Q3 2022 was Kayne Anderson Rudnick Investment Management, an estimated $704K sold.

Based on aggregated 13F filings for Q3 2022.